# Physiological Versus Right Ventricular Outcome Trial Evaluated for Bradycardia Treatment Upgrades

Study · id `cardio:ct-nct06052475` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06052475](<https://clinicaltrials.gov/study/NCT06052475>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06052475

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 155 participants.

## Technical summary

Registry record NCT06052475. Randomized; quadruple masking; primary purpose treatment. Start 2023-09-04 (actual); primary completion 2026-09-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 155 participants (planned count; ClinicalTrials.gov record NCT06052475, source copy `cardio:ctgov-nct06052475-2026-06-23`, retrieved 2026-10-26)
- Started: 2023-09-04 (actual) (ClinicalTrials.gov record NCT06052475, source copy `cardio:ctgov-nct06052475-2026-06-23`, retrieved 2026-10-26)
- Primary completion: 2026-09-30 (anticipated) (ClinicalTrials.gov record NCT06052475, source copy `cardio:ctgov-nct06052475-2026-06-23`, retrieved 2026-10-26)
- Completion: 2027-09-04 (anticipated) (ClinicalTrials.gov record NCT06052475, source copy `cardio:ctgov-nct06052475-2026-06-23`, retrieved 2026-10-26)
- Countries: United Kingdom (ClinicalTrials.gov record NCT06052475, source copy `cardio:ctgov-nct06052475-2026-06-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06052475-2026-06-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: Physiological Versus Right Ventricular Outcome Trial Evaluated for Bradycardia Treatment Upgrades
- Acronym: PROTECT-UP
- Condition: Pacing-Induced Cardiomyopathy
- Condition: Heart Failure
- Intervention (Device): Physiological Pacing Upgrade (Conduction System Pacing or Biventricular Pacing)
- Intervention (Device): Continued RV Pacing (Right Ventricular Pacing)
- Lead sponsor: Imperial College London
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Imperial College London (`cardio:org-imperial-college-london`)

## Provenance

Content hash: c90f1553d8f6c306bbf689f82350a07b58f7070cd45e91b666bf1b0587b6ea4f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
